Concepedia

Dasatinib Suppresses TGFβ-Mediated Epithelial–Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis

Ryota Kanemaru, Fumiyuki Takahashi, Motoyasu Kato, Yoichiro Mitsuishi, Ken Tajima, Hiroaki Ihara, Moulid Hidayat, Aditya Wirawan, Yoshika Koinuma, Daisuke Hayakawa,

Lung · 2018 · 23 citations · 28 references

DOI

Concepts

References

28

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi, Roland M. du Bois, Ganesh Raghu et al. · New England Journal of Medicine · 2014 · 4.6K citations · Full text

, , +13

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini et al. · New England Journal of Medicine · 2014 · 3.9K citations · Full text

, , +13

Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor

Neil P. Shah, Chris Tran, Francis Y. Lee et al. · Science · 2004 · 1.8K citations

, , +14

Simple method of estimating severity of pulmonary fibrosis on a numerical scale.

T Ashcroft, Judy M. Simpson, V. Timbrell · Journal of Clinical Pathology · 1988 · 1.7K citations

, , +15

TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT)

Hidenori Kasai, Jeremy Allen, Roger M. Mason et al. · Respiratory Research · 2005 · 742 citations · Full text

, , +15